herenciageneticayenfermedad: Drug Discovery and Production | Medical News | Medical Articles

jueves, 26 de marzo de 2020

Drug Discovery and Production | Medical News | Medical Articles | Drug Discovery and Production |

	Drug Discovery and Production
	Reagents for Serological Analysis of SARS-CoV-2

Pharmaceuticals: Characterization for Solid Dosage Forms

Quality by Design (QbD) calls for exploration of the design space of a product and identification of Critical Quality Attributes (CQAs) those physical, chemical, biological, or microbiological properties or characteristics that impact and define clinical efficacy. Comprehensive physicochemical characterization is essential.

Reagents for Serological Analysis of SARS-CoV-2

There is an urgent need to increase the current diagnostic capacity for COVID-19. Compared with the commonly-used PCR testing, serological assay-based diagnostic method is much easier and faster to perform. To support the development of immunodiagnostic assay, Sino Biological has developed a comprehensive collection of antigens and antibodies for SARS-CoV-2.

Find Out More

Accelerate Drug Discovery Research with the Correct Pipettes

VOYAGER pipettes are perfect for sample formatting between different labware because, depending on configuration, tip spacing can adjust automatically between 4.5 and 33 mm at the push of a button.

Learn More

	Drug Discovery, Manufacturing, and Development The process starting from the creation of a new molecule until its introduction into clinical use is broadly referred to as drug development.

	Balance Calibration in the Pharmaceutical Industry The aim of the calibration procedure is to establish the accuracy of the equipment being used.

	What is In Silico Toxicology? In silico toxicology allows researchers to visualize, analyze, simulate and predict potential toxicity of chemicals prior to cell or animal work.

	New collapsible basket technology has big advantages for drug discovery, personalized medicine A drug discovery scientist typically screens up to 10,000 compounds in the early stages of developing one FDA approved drug. During this high-throughput screening, candidate compounds are initially tested on cell and tissue samples.